<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000044915"><TermName>antigen-presenting cell vaccine</TermName><TermPronunciation>(AN-tih-jen-preh-ZEN-ting sel vak-SEEN)</TermPronunciation><TermDefinition><DefinitionText>A vaccine made of antigens and antigen-presenting cells (APCs). APCs boost an immune response by presenting antigens on their surfaces to other cells of the immune system. Also called APC vaccine.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000706134" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;antigen-presenting cell vaccine&quot;" language="en" id="_3"/><MediaLink ref="CDR0000706133" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;vacuna de célula presentadora de antígeno&quot;" language="es" id="_4"/><SpanishTermName>vacuna de célula presentadora de antígeno</SpanishTermName><SpanishTermDefinition><DefinitionText>Vacuna elaborada con antígenos y células presentadoras de antígenos (CPA). Las CPA estimulan una respuesta inmunitaria porque se presentan ante otras células del sistema inmunitario con antígenos en sus superficies. También se llama vacuna CPA.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2010-08-27</DateLastModified></GlossaryTerm>
